1. Cell Cycle/DNA Damage Metabolic Enzyme/Protease Immunology/Inflammation NF-κB
  2. ClpP Reactive Oxygen Species (ROS) Mitochondrial Metabolism
  3. ClpP activator-2

ClpP activator-2 (Compound GU18) 是一种 ClpP 激活剂,对 HsClpP 的 Kd 为 5.01 μM。ClpP activator-2 可增强 HsClpP 的蛋白水解活性,促进 HsClpP 对 α-casein 的降解,其 EC50 为 1.09 μM。ClpP activator-2 可诱导线粒体活性氧 (ROS) 的积累,引发线粒体结构与功能损伤。ClpP activator-2 具有显著的体内抗多发性骨髓瘤活性。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

ClpP activator-2

ClpP activator-2 Chemical Structure

CAS No. : 3036751-71-7

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

ClpP activator-2 (Compound GU18) is a ClpP activator with a Kd of 5.01 μM for HsClpP. ClpP activator-2 enhances the proteolytic activity of HsClpP and promotes the degradation of α-casein by HsClpP, with an EC50 of 1.09 μM. ClpP activator-2 induces the accumulation of mitochondrial reactive oxygen species (ROS), leading to damage to mitochondrial structure and function. ClpP activator-2 exhibits significant in vivo anti-multiple myeloma activity[1].

体外研究
(In Vitro)

ClpP activator-2 强效激活纯化的 HsClpP,其 EC50 为 0.54 ± 0.12 μM[1]
ClpP activator-2 (2 h) 可促进 HsClpP 对 α-casein 的降解,其 EC50 为 1.09 ± 0.08 μM[1]
ClpP activator-2 可与纯化的 HsClpP 结合,通过 ITC 测得其解离常数 Kd 为 5.01 ± 1.05 μM[1]
ClpP activator-2 (0.45 μM; 24 h) 可在 0.45 μM 处理 24 h 后对 AMO.1 MM 细胞造成显著的线粒体超微结构损伤[1]
ClpP activator-2 (0.15-0.6 μM; 48 h) 可在处理 48 h 后,以浓度依赖的方式促进 AMO.1 和 ARP1 多发性骨髓瘤 (MM) 细胞中线粒体活性氧 (ROS) 的积累[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Human multiple myeloma cell lines AMO.1, ARP1
Concentration: Gradient concentrations
Incubation Time: 24 h, 48 h, 72 h
Result: Reduced cell viability in a time- and concentration-dependent manner.
For AMO.1 cells, reached IC50 values of 1.30 ± 0.08 μM (24 h), 0.68 ± 0.03 μM (48 h), and 0.08 ± 0.01 μM (72 h).
For ARP1 cells, reached IC50 values of 1.81 ± 0.14 μM (24 h), 0.86 ± 0.08 μM (48 h), and 0.21 ± 0.02 μM (72 h).

Cell Cycle Analysis[1]

Cell Line: Human multiple myeloma cell lines AMO.1, ARP1
Concentration: 0.15-0.6 μM
Incubation Time: 24 h
Result: Induced dose-dependent G1 phase.

Apoptosis Analysis[1]

Cell Line: Human multiple myeloma cell lines AMO.1, ARP1
Concentration: 0.15-0.6 μM (apoptosis assay); 0.45 μM (Western blotting)
Incubation Time: 24 h, 48 h, 72 h (apoptosis assay); 48 h (Western blotting)
Result: Induced time- and concentration-dependent apoptosis, with 95% of AMO.1 cells and 73.8% of ARP1 cells apoptotic after 72 h of 0.6 μM treatment.
Upregulated cleaved caspase-3.
药代动力学
(Parmacokinetics)
Species Dose Route Cmax T1/2 Bioavailability
Rat[1] 5 mg/kg i.v. 16733.33 ng/mL 3.854 h 38.9 %
Rat[1] 10 mg/kg p.o. 6050 ng/mL 3.198 h /
体内研究
(In Vivo)

ClpP activator-2 (5-30 mg/kg;腹腔注射;隔日一次;14 天) 可剂量依赖性地抑制 NOD/SCID 小鼠体内多发性骨髓瘤的肿瘤生长[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: NOD/SCID (female, 6-8 weeks old, subcutaneous xenograft model)[1]
Dosage: 5 mg/kg; 15 mg/kg; 30 mg/kg
Administration: i.p.; every other day; 14 days
Result: Achieved 56.7% tumor volume inhibition at 5 mg/kg.
Achieved 83.4% tumor volume inhibition at 15 mg/kg.
Achieved 91.4% tumor volume inhibition at 30 mg/kg.
Showed no treatment-related damage to major organs in the 30 mg/kg group compared to controls.
分子量

483.31

Formula

C22H19Cl2F3N4O

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
ClpP activator-2
目录号:
HY-181934
需求量: